Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1863L |
Glucagon (19-29), human acetate
|
Glucagon Receptor | GPCR/G Protein |
Glucagon (19-29), human acetate 是一种从胰高血糖素加工而来的 COOH 末端片段,是一种有效的胰岛素分泌抑制剂。 | |||
T15389L |
Glucagon (1-29), bovine, human, porcine hydrochloride
盐酸胰高血糖素,Porcine glucagon hydrochloride,Glucagon hydrochloride |
Glucocorticoid Receptor; Glucagon Receptor | Endocrinology/Hormones; GPCR/G Protein |
Glucagon (1-29), bovine, human, porcine hydrochloride 是一种由胰腺 α 细胞产生的多肽激素。它可激活 HNF4α 并促进 HNF4α 磷酸化,促进糖异生。 | |||
TP1863 |
Glucagon (19-29), human
|
||
Glucagon is a 29-amino-acid peptide hormone liberated in the alpha cells of the islets of Langerhans. Glucagon-producing alpha cells represent one of the earliest populations of detectable islet cells in the developing endocrine pancreas. | |||
T78059 |
Glucagon (Human)
Hyperglycemic-glycogenolytic factor,Glukagon |
Others | Others |
Glucagon 对蛋白质和氨基酸的代谢产生显著的调节作用。它抑制了氨基酸与肝脏、肌肉以及胰腺蛋白的结合,增加氮的排出,并促进肝脏内尿素的合成。同时,Glucagon 增加了肝脏中转氨酶和尿素循环酶的浓度,提高了肝脏对氨基酸的摄取,并加强了氨基酸与肝糖原之间的结合,从而降低了血液中的氨基酸浓度。 | |||
T15389 |
Glucagon (1-29), bovine, human, porcine
胰高血糖素,Porcine glucagon,Glucagon |
Others | Others |
Glucagon is a peptide hormone, produced by pancreatic α-cells. Glucagon reduces the activity of HNF-4. Glucagon stimulates gluconeogenesis. Glucagon enhances HNF4α phosphorylation. | |||
TP1148L |
Glucagon-like peptide 1 (1-37), human acetate
|
Glucagon Receptor | GPCR/G Protein |
Glucagon-like peptide 1 (1-37), human acetate 是一种高效的 GLP-1 受体激动剂。 | |||
TP1487 |
Glucagon-Like Peptide (GLP) II, human
|
||
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a po | |||
TP1148 |
Glucagon-like peptide 1 (1-37), human
HuGLP-1 |
||
Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on food intake in rats and does not en | |||
TP1147 |
Glucagon-like peptide 1 (1-37), human TFA
HuGLP-1 TFA |
||
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon. | |||
TP1157 |
GLP-2(1-33)(human)
GLP-2 (human),Glucagon-like peptide 2 (human) |
||
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium. | |||
T80453 |
GLP-1 (1-36) amide (human, rat)
Glucagon-like Peptide 1 (1-36) amide (human, rat) |
||
GLP-1(1-36) amide (human, rat)(人类及大鼠的胰高血糖素样肽1(1-36)酰胺)是GLP-1(7-36)酰胺的一种分子变体。该化合物能激发[14C]氨基吡啶在大鼠胃壁细胞的酶分散体中积累。 | |||
T3984 |
GLP-1(7-36), amide
MKC 253,胰高血糖素样肽-1,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide |
Glucagon Receptor | GPCR/G Protein |
GLP-1(7-36), amide (MKC 253) 是一种生理性肠降血糖素,能够刺激胰岛素分泌。 | |||
T82309 |
GLP-1 (1-36) amide (human, rat) (TFA)
Glucagon-like Peptide 1 (1-36) amide (human, rat) (TFA) |
||
GLP-1(1-36) amide (human, rat) TFA为胰高血糖素样肽1(GLP-1)-(7-36)酰胺的分子变体,能够促进[14C]氨基吡啶在大鼠壁细胞的酶分散体中的积累。 | |||
T76332 |
Biotinyl-Glucagon (1-29), human, bovine, porcine
|
||
Biotinyl-Glucagon (1-29), human, bovine, porcine 为带生物素标记的Glucagon衍生物,此肽类激素由胰腺α细胞分泌,功能是提升血液中的葡萄糖与脂肪酸浓度。 | |||
T83550 |
(Asp28)-Glucagon (1-29) (human, rat, porcine)
|
||
'(Asp28)-Glucagon (1-29) (human, rat, porcine)' 为胰高血糖素的一种改良型结构,在第28位氨基酸残基上天冬氨酸(Asp)替换原有残基,显著提高了该化合物在生理pH条件下的溶解性,且保持了与天然胰高血糖素相同的生物活性。 | |||
T76628 |
(Met(O)27)-Glucagon (1-29) (human, rat, porcine)
|
||
'(Met(O)27)-Glucagon (1-29) (human, rat, porcine) 为修饰版胰高血糖素。在大鼠肝细胞内,其促进葡萄糖合成的活性虽与天然胰高血糖素相似,但呈现出较低效率,暗示蛋氨酸对于胰高血糖素与其肝脏受体绑定具有关键性作用。' | |||
T76330 |
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide
|
||
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide 是一种带有生物素标签的Glucagon-like peptide-1-(7-36),后者为一种具备提升胰岛素释放功能,从而表现出抗糖尿病活性的胃肠道肽。 | |||
T76085 |
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human
|
||
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human 是一种被 C 端标记的生物素化 GLP-1(7-36) 酰胺。 | |||
T7364 |
NNC-0640
|
Glucagon Receptor | GPCR/G Protein |
NNC-0640 是人类胰高血糖素受体阴性变构调节剂(IC50:69.2 nM)。 | |||
T22893 |
L-168049
L-168,049 |
Glucagon Receptor | GPCR/G Protein |
L-168049 是一种选择性和非竞争性人胰高血糖素受体拮抗剂,对人、鼠和犬的 IC50 分别为 3.7 nM、63 nM 和 60 nM。 | |||
T36579 |
GLP-1R Agonist DMB
|
Glucagon Receptor | GPCR/G Protein |
GLP-1R Agonist DMB 是胰高血糖素样肽1受体的激动剂(GLP-1R;重组人受体的 KB=26.3nM)。 | |||
T19850 |
Semaglutide
索玛鲁肽,司美格鲁肽,索马鲁肽 |
Glucagon Receptor | GPCR/G Protein |
Semaglutide 是人胰高血糖素样肽-1受体激动剂,是一种人胰高血糖素样肽-1 的长效类似物。它有用于 2 型糖尿病研究的潜力。 | |||
T3422 |
GRA Ex-25
GRA-Ex-25 |
Glucagon Receptor | GPCR/G Protein |
GRA Ex-25 (GRA-Ex-25) 是glucagon 受体抑制剂,其对大鼠和人的 glucagon 受体的IC50值分别为 56 和 55 nM。 | |||
T37223 |
Glucagon Receptor Antagonist I
|
||
Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM). It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver. Glucagon receptor antagonist I, at 50 mg/kg, reduces the increase in glucose levels observed after intraperitoneal administration of glucagon in humanized mice. Glucagon receptor antagonist inactive control does not prevent glucagon-mediated actions. | |||
T36428 |
PACAP-related Peptide (human) (trifluoroacetate salt)
|
PACAP | GPCR/G Protein |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adenylate cyclase-activating polypeptide . It is expressed in normal human pancreas and adrenal gland tissue and in some tumors that produce vasoactive intestinal peptide (VIP). PRP (1-29) is secreted by CHO-K1 cells that express human recombinant preproPACAP. | |||
T81585 |
Oxyntomodulin (human, mouse, rat)
Proglucagon (33-69) |
||
Oxyntomodulin (human, mouse, rat) (Proglucagon (33-69)) 是由胰高血糖素前体产生,融合了完整胰高血糖素序列和C端八肽,含37个氨基酸。 | |||
T36072 |
Skyrin
Endothianin,Rhodophyscin |
||
Skyrin is a fungal metabolite characterized by a bisanthraquinone structure. It interferes with glucagon signaling through adenylate cyclase without binding to the glucagon receptor. At 10 μM, skyrin reduces both glucagon-stimulated cAMP production and glycogenolysis. It does not interfere with epinephrine or glucagon-like peptide 1 effects on these parameters.[1] Reference:[1]. Parker, J.C., McPherson, R.K., Andrews, K.M., et al. Effects of skyrin, a receptor-selective glucagon antagonist, in r... | |||
T80565 |
Gulgafafusp alfa
|
||
Gulgafafusp alfa 为人源化IgG2κ类抗体,专一性靶向GLP1R(胰高血糖素样肽1受体)。 | |||
T77791 |
Dasiglucagon
|
||
Dasiglucagon是一种稳定的人胰高血糖素肽类似物,用于治疗严重低血糖,具有快速且有效的特点。 | |||
T72621 |
GCGR antagonist 2
|
||
GCGR antagonist2 是一种呋喃-2-碳酰肼化合物,是具有口服活性的胰高血糖素受体拮抗剂。GCGR antagonist2 与 hGluR 结合的 Kd 值为 2.3 nM,抑制大鼠受体的 IC50值为 0.43 nM。GCGR antagonist2 可抑制胰高血糖素刺激的糖原分解。 | |||
T37577 |
Glycogen Phosphorylase Inhibitor
|
||
Glycogen phosphorylase in the liver, muscle, and brain initiate glycogenolysis by releasing glucose-1-phosphate from glycogen. Glycogen phosphorylase inhibitor is a cell-permeable acyl urea first identified as an inhibitor of human liver glycogen phosphorylase (IC50 = 53 nM). It blocks glucagon-induced hepatic glycogenolysis in vivo. Glycogen phosphorylase inhibitor has been used to study glycogen utilization in human liver HepG2 cells, retinal explants, and human T lymphocyte Kit 225 cells. | |||
T80149 |
GRPP (human)
|
||
GRPP (human)为含有30个氨基酸的Gcg衍生肽。该化合物能引起血浆胰岛素的轻微上升及血浆胰高血糖素的轻微降低,但不会影响大鼠胰岛内的胰岛素分泌。 | |||
T75822 |
GLP-1(9-36)amide TFA
|
||
GLP-1(9-36)amide TFA, 作为胰高血糖素样肽-1 (7-36)amide的主要代谢产物,是人胰腺GLP-1受体的拮抗剂。 | |||
T36380 |
GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt)
|
||
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and truncated GLP-1 (7-36) amide , in pancreatic tissue compared to wild-type mice.2References1. Schjoldager, B.T., Mortensen, P.E., Christiansen, J., et al. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans... | |||
T76862 |
Crotedumab
|
||
Crotedumab (REGN1193) 是一种人源化的 IgG4单克隆抗体,可结合并抑制胰高血糖素受体 (GCGR),KD 值为 0.1 nM。Crotedumab 可用于糖尿病的研究。 | |||
T80084 |
Retatrutide acetate
LY3437943 acetate |
||
Retatrutide (LY3437943) acetate 是一种针对胰高血糖素受体(GCGR)、葡萄糖依赖性促胰岛素多肽受体(GIPR)和胰高血糖素样肽-1 受体(GLP-1R)的三重肽激动剂。该化合物能有效抑制这三种受体,其EC50值分别为GCGR 5.79 nM、GIPR 0.0643 nM和GLP-1R 0.775 nM,是肥胖研究领域的潜在工具。 | |||
T75787 |
Amylin, amide, human TFA
|
||
Amylin, amide, human TFA 是一种含有37个氨基酸的胰腺多肽,与胰岛素共同分泌,对代谢和维持葡萄糖稳态具有重要作用。该化合物能够抑制胰高血糖素的分泌,延缓胃排空速度,同时作为增加饱腹感的因子。 | |||
T76333 |
(Ser8)-GLP-1 (7-36) amide, human
|
||
(Ser8)-GLP-1 (7-36) amide, human 为源自胰高血糖素原的胰高血糖素样肽-1酰胺,属于 GLP-1(1-36) 酰胺肽裂解产物。作为肠促胰岛素激素,该化合物促进胰腺 β 细胞在葡萄糖依赖性条件下分泌胰岛素,并对消化道的运动与分泌功能产生影响。 | |||
T73694 |
Albiglutide TFA
|
||
Albiglutide TFA 是一种胰高血糖素样肽GLP-1模拟物,是长效的GLP-1受体激动剂。Albiglutide TFA 可显著降低糖化血红蛋白 (A1C)。Albiglutide TFA 可用于研究 2 型糖尿病 (T2D)。Albiglutide TFA 是由抗DPP-4的GLP-1二聚体与人白蛋白的基因融合产生的。 | |||
T21691 |
NVP DPP 728 dihydrochloride
|
||
NVP-DPP728 是一种有效、可逆、腈依赖性二肽基肽酶 IV (DPP-IV)抑制剂,Ki 值为 11 nM。NVP-DPP728 可抑制胰高血糖素样肽-1 (GLP-1)的降解,从而增强响应于葡萄糖摄入的胰岛素释放。NVP-DPP728 可用于糖尿病研究。 | |||
TP1302 |
Somatostatin
|
||
Somatostatin, also known as growth hormone-inhibiting hormone, is a naturally-occurring peptide hormone of 14 or 28 amino acid residues that regulates the endocrine system. It is secreted by the D cells of the islets to inhibit the release of insulin and | |||
T36427 |
PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)
|
PACAP | GPCR/G Protein |
Pituitary adenylate cyclase-activating peptide (PACAP) (6-27) is a PACAP receptor antagonist with IC50 values of 1,500, 600, and 300 nM, respectively, for rat PAC1, rat VPAC1, and human VPAC2 recombinant receptors expressed in CHO cells. It binds to PACAP receptors on SH-SY5Y and SK-N-MC human neuroblastoma and T47D human breast cancer cells (IC50s = 24.5, 106, and 105 nM, respectively) and inhibits cAMP accumulation induced by PACAP (1-38) (Kis = 457, 102, and 283 nM, respectively, in SH-SY5Y, ... | |||
T83906 |
Tirzepatide sodium
LY3298176 |
||
Tirzepatide 是一种glucagon-like peptide 1 receptor (GLP-1R) 和 G protein-coupled receptor 119 (GPR119)的激动剂。它在表达人类GLP-1R或GPR119的HEK293细胞中诱导cAMP的产生(EC50s分别为6.54和1.01 nM)。Tirzepatide(100 nM)在表达人类GLP-1R或GPR119的HEK293细胞中诱导受体内化。在体内,Tirzepatide(每天10 nmol/kg)降低高脂饮食诱导的肥胖小鼠模型的体重、食物摄入量、血浆leptin、三酸甘油酯和free fatty acids (FFAs)水平、肝脏三酸甘油酯和血糖水平。它通过每三天给药50 nmol/kg的剂量,阻止A. alternata诱导的A. alternata挑战小鼠的支气管肺泡灌洗液(BALF)中嗜酸性粒细胞和淋巴细胞数量的增加。Tirzepatide(每三天50 nmol/kg)抑制由毒蕈碱受体激动剂methacholine (acetyl-β-methylcholine)导致的在糖尿病诱导的哮喘... |